Differences in patterns of TP53 and KRAS2 mutations in a large series of endometrial carcinomas with or without microsatellite instability

Cancer

Volumn 85, Issue 1, 1999, Pages 119-126

  Swisher, Elizabeth M ^a   Peiffer Schneider, Stacia ^a   Mutch, David G ^a   Herzog, Thomas J ^a   Rader, Janet S ^a   Elbendary, Alaa ^a   Goodfellow, Paul J ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Dept of Obstetrics and Gynecology ^*  (United States)

Author keywords

Endometrial carcinoma; KRAS2; Microsatellite instability; Mismatch repair; Replication error; TP53

Indexed keywords

ABDOMINAL HYSTERECTOMY; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; DNA REPAIR; DNA SEQUENCE; ENDOMETRIUM CARCINOMA; FEMALE; GENE MUTATION; GENE REPLICATION; GENETIC ANALYSIS; GENETIC MODEL; HUMAN; HUMAN TISSUE; MICROSATELLITE INSTABILITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

DNA REPAIR; ENDOMETRIAL NEOPLASMS; FEMALE; GENES, P53; HUMANS; MICROSATELLITE REPEATS; MUTATION; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTO-ONCOGENE PROTEINS;

EID: 0032953788     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990101)85:1<119::AID-CNCR17>3.0.CO;2-5     Document Type: Article

References (42)

1. Burks RT, Kessis TD, Cho KR, Hedrick L. Microsatellite instability in endometrial carcinoma. Oncogene 1994;9: 1163-6.
2. Peiffer SL, Herzog TJ, Tribune DI, Mutch DG, Gersell DJ, Goodfellow PJ. Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers. Cancer Res 1995;55:1922-6.
3. Kobayashi K, Sagae S, Kudo R, Saito H, Koi S, Nakamura Y. Microsatellite instability in endometrial carcinomas: frequent replication errors in tumors of early onset and/or of poorly differentiated type. Genes Chromosomes Cancer 1995; 14:128-32.
4. Parsons R, Li G-M, Longley MJ, Fang W-H, Papadopoulos N, Jen J, et al. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 1993;75:1227-36.
5. Bocker T, Diermann J, Friedl W, Gebert J, Holinski-Feder E, Karner-Hanusch J, et al. Microsatellite instability analysis: a multicenter study for reliabilty and quality control. Cancer Res 1997;57:4739-43.
6. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary nonpolyposis colon cancer. Nature 1994;368:258-61.
7. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993;75:1215-25.
8. Nicolaides NC, Papadopoulos N, Liu B, Wei Y-F, Carter KC, Ruben SM, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994;371:75-80.
9. Fishel R, Lescoe MK, Rao MRS, Copeland NG, Jenkins NA, Garber J, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993;75:1027-38.
10. Papadopoulos N, Nicolaides NC, Wei Y-F, Ruben SM, Carter KC, Rosen CA, et al. Mutation of a mutL homolog in hereditary colon cancer. Science 1994;263:1625-9.
11. Herfarth K-F, Kodner IJ, Whelan AJ, Ivanovich JL, Bracamontes JR, Wells SA Jr., et al. Mutations in MLH1 are more frequent than in MSH2 in sporadic colorectal cancers with microsatellite instability. Genes Chromosomes Cancer 1997; 18:42-9.
12. Liu B, Nicolaides NC, Markowitz S, Wilson JKV, Parsons RE, Jen J, et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet 1995; 9:48-55.
13. Kowalski LD, Mutch DG, Herzog TJ, Rader JS, Goodfellow PJ. Mutational analysis of MLH1 and MSH2 in 25 prospectively-acquired RER+ endometrial cancers. Genes Chromosomes Cancer 1997;18:219-27.
14. Lu S-L, Zhang W-C, Akiyama Y, Nomizu T, Yuasa Y. Genomic structure of the transforming growth factor-β type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers. Cancer Res 1996;56:4595-8.
15. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, et al. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 1995;268:1336-8.
16. Parsons R, Myerhoff LL, Liu B, Wilson JKV, Markowitz SD, Kinzler KW, et al. Microsatellite instability and mutations of the transforming growth factor-β type II receptor gene in colorectal cancer. Cancer Res 1995;55:5548-50.
17. Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC, et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997;275:967-9.
18. Tashiro H, Blazes MS, Wu R, Cho KR, Bose S, Wang SI, et al. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 1997;57:3935-40.
19. Teng DHF, Hu R, Lin H, Davis T, Iliev D, Frye C, et al. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res 1997;57:5221-5.
20. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993;363:558-61.
21. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1995;260:816-9.
22. Bocker T, Schlegel J, Kullmann F, Stumm G, Zirngibl H, Epplen JT, et al. Genomic instability in colorectal carcinomas: comparison of different evaluation methods and their biological significance. Gastroenterology 1996;179:15-9.
23. Kohler MF, Berchuck A, Davidoff AM, Humphrey PA, Dodge RK, Iglehart JD, et al. Overexpression and mutation of p53 in endometrial carcinoma. Cancer Res 1992;52:1622-7.
24. Enomoto T, Fujita M, Inoue M, Rice JM, Nakajima R, Tanizawa O, et al. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. Cancer Res 1993;53:1883-8.
25. Duggan BD, Felix JC, Muderspach LI, Tsao J-L, Shibata DK. Early mutational activation of the c-Ki-ras oncogene in endometrial cancer. Cancer Res 1994;54:1604-7.
26. Ignar-Trowbridge D, Risinger JI, Dent GA, Kohler M, Berchuck A, McLachlan JA, et al. Mutations of the Ki-ras oncogene in endometrial carcinoma. Am J Obstet Gynecol 1992; 167:227-32.
27. Sasaki H, Nishii H, Takahashi H, Tada A, Furusato M, Terashima Y, et al. Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma. Cancer Res 1993;53:1906-10.
28. Lahiri DK, Nurnberger JIA. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991;19:5444.
29. FIGO stages: 1988 revision. Gynecol Oncol 1989;35:125-7.
30. Herfarth KK-F, Wick MR, Marshall HN, Gartner E, Lum S, Moley JF. Absence of TP53 alterations in pheochromocytomas and medullary thyroid cancers. Genes Chromosomes Cancer 1997;20:24-9.
31. Lin S-Y, Chen P-H, Wang C-K, Liu J-D, Siauw C-P, Chen Y-J, et al. Mutation analysis of K-ras oncogenes in gastroenterologic cancers by the amplified created restriction method. Am J Clin Pathol 1993;100:656-89.
32. Fujimoto I, Shimizu Y, Hirai Y, Chen J-T, Teshima H, Hasumi K, et al. Studies on ras oncogene activation in endometrial carcinoma. Gynecol Oncol 1993;48:196-202.
33. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, et al. Mutations in the RET proto-oncogene are associated with MEN-2A and FMTC. Hum Mol Genet 1993;2:851-6.
34. Jovanovic AS, Boynton KA, Mutter GL. Uteri of women with endometrial carcinoma contain a histopathological spectrum of monoclonal putative precancers, some with microsatellite instability. Cancer Res 1996;56:1917-21.
35. Aaltonen LA, Peltomaki P, Mecklin JP, Jarvinen H, Jass JR, Green JS, et al. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 1994;54:1645-8.
36. Ilyas M, Tomlinson IPM, Novelli MR, Hanby A, Bodmer WF, Talbot IC. Clinicopathological features and p53 expression in left-sided sporadic colorectal cancers with and without microsatellite instability. J Pathol 1996;179:370-5.
37. Watatani M, Yoshida T, Kuroda K, Ieda S, Yasutomi M. Allelic loss of chromosome 17p, mutation of the p53 gene, and microsatellite instability in right- and left-sided colorectal cancer. Cancer 1996;77(Suppl):1688-93.
38. Konishi M, Kikuchi-Yanoshita R, Tanaka K, Muraoka M, Onda A, Okumura Y, et al. Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis and sporadic colon cancer. Gastroenterology 1996;111:307-17.
39. Caduff RF, Johnston CM, Svoboda-Newman SM, Poy EL, Merajver SD, Frank TS. Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma. Am J Pathol 1996;148:1671-8.
40. Ito K, Watanabe K, Nasim S, Sasano H, Sato S, Yajima A, et al. Prognostic significance of p53 overexpression in endometrial cancer. Cancer Res 1994;54:4667-70.
41. Ito K, Watanabe K, Nasim S, Sasano H, Sato S, Yajima A, et al. K-ras point mutations in endometrial carcinoma: effect on outcome is dependent on age. Gynecol Oncol 1996;63: 238-46.
42. Enomoto T, Fujita M, Inoue M, Nomura T, Shroyer KR. Alteration of the p53 tumor suppressor gene and activation of the c-K-ras-2 protooncogene in endometrial adenocarcinoma from Colorado. Anat Pathol 1993;103:224-30.